from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1590/-

LFCtreatmentdescriptionclass of inhibitor

-0.168

Amikacinug/mL Amikacintranslation

-1.391

Cap5-10ug/mL Capreomycintranslation

-1.609

Rox10-50 ug/mL Roxithromycintranslation

0.470

SM2-5 ug/mL Streptomycintranslation

-0.358

Tet5-10 ug/mL Tetracyclinetranslation

0.919

Rif0.2-5ug/mL Rifampicintranscription

0.023

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.269

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.372

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.558

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.557

Clofazimine10-13 ug/mL Clofaziminerespiration

0.456

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.542

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.457

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.302

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.383

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.755

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.303

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.318

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.554

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.157

KCN5-20 ug/mL Potassium cyaniderespiration

0.320

NaN30.2-2 mM Sodium aziderespiration

-0.060

Nigericin50 uM Nigericinrespiration

-0.725

TRC10-150 ug/mL Triclosanrespiration

-1.811

TRZ10-25 ug/mL Thioridazinerespiration

-1.391

Valinomycin0.5-10 uM Valinomycinrespiration

0.688

ZnSO42 mM ZnSO4respiration

-0.573

menadione6-10 ug/mL Menadionerespiration

-0.132

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.428

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.149

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.244

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.283

NRP_1Non-replicating persistence stage 1dosRassociated

0.311

Amp0.2mg/mL AmpicillincellWall

0.653

Cephalexin20-100 ug/mL CephalexincellWall

0.198

Cerulenin0.32-5 ug/mL CerulenincellWall

0.262

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.274

EMB10-20 ug/mL EthambutolcellWall

0.568

Eta12-40 ug/mL EthionamidecellWall

1.029

INH0.2-0.4 ug/mL IsoniazidcellWall

0.252

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.158

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.512

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.750

BZA0.12 mg/mL BenzamidearomaticAmides

0.468

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.688

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.645

H2O24 mM hydrogen peroxideDNAdamaging

1.258

Levo10 ug/mL LevofloxacinDNAdamaging

0.642

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.837

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.595

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.866

UVUV-irradiationDNAdamaging

-0.612

ARP41-4 ug/mL Antitubercular compound ARP4?

0.419

Antimycin12.5-50 ug/mL Antimycin A?

0.150

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.324

PA_110-50 ug/mL Antitubercular compound PA-1?

0.353

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.797

PA8240.2-2 ug/mL PA-824?

-0.376

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.770

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.430

Verapamil50 uM Verapamil?

0.462

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.020

methoxatin10-20 ug/mL Methoxatin?